NCT03126825View on ClinicalTrials.gov

CLEAR Clinical Study

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 13, 2017

Study Completion Date

September 1, 2017

Conditions
Hearing Loss
Interventions
DEVICE

CP910/CP920 with noise reduction on

This intervention uses the approved Nucleus 6 system (CP910/CP920 and accessories) but adds the investigational noise reduction algorithm.

DEVICE

CP910/CP920

The approved CP910 or CP920 Sound Processor.

Trial Locations (2)

2109

Cochlear Limited Sydney, Sydney

3002

Cochlear Limited Melbourne, Melbourne

Sponsors

Lead Sponsor

Cochlear
All Listed Sponsors
lead

Cochlear

INDUSTRY

NCT03126825 - CLEAR Clinical Study | Biotech Hunter | Biotech Hunter